Trial Profile
Study of patients with psoriatic arthritis who initiated secukinumab and other biologics
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Nov 2018
Price :
$35
*
At a glance
- Drugs Secukinumab (Primary) ; Abatacept; Adalimumab; Certolizumab pegol; Etanercept; Golimumab; Infliximab; Ustekinumab
- Indications Psoriatic arthritis
- Focus Therapeutic Use
- 21 Nov 2018 New trial record
- 24 Oct 2018 Results presented at the 82nd American College of Rheumatology and the 52nd Association of Rheumatology Health Professionals Annual Scientific Meeting